Denali Therapeutics Inc. Common Stock (NASDAQ: DNLI) last traded at $18.95, down 2.57% on the session. The quote above updates while this page is open; the figures below are drawn from Denali Therapeutics Inc. Common Stock’s own filings and are restated only when a new one is published.
Denali Therapeutics Inc. Common Stock trades on NASDAQ under the ticker DNLI. Its market capitalisation is $3.03 billion.
Valuation measures for Denali Therapeutics Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $3.03B |
|---|---|
| Enterprise value | $3.15B |
| Price / book | 3.63 |
| Beta | 1.52 |
Trailing-twelve-month figures tagged in Denali Therapeutics Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $0.00 |
| Net income (TTM) | -$511.45M |
|---|
| EPS (TTM) | -$2.84 |
|---|
| Return on equity | -61.24% |
|---|
| Cash | $201.53M |
|---|
Range and volume for DNLI over the past 52 weeks.
| 52-week high | $27.30 |
|---|---|
| 52-week low | $13.75 |
| Volume | 1.23M |
| Average volume | 1.61M |
| Previous close | $19.45 |
Invest a chosen dollar amount in Denali Therapeutics Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell DNLI.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.